LivingGLP1
Study S002711

AIManage: Using an AI-driven CDS and Chatbot for the Management of Patients on Incretin Mimetic Medications

ClinicalTrials.gov record

Registration

Registration
NCT07546357
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
16
Start
2026-06-01
Primary completion
2028-03-30
Lead sponsor
NYU Langone Health
Conditions
Diabetes; Obesity; Medication Side Effects
Interventions
OTHER:AIManage
Results posted
FALSE
Individual participant data sharing
YES
Secondary identifiers
NIH:1R01DK144008

Registered primary outcomes

  • Percentage of Patients who Complete Qualitative Measure - Perceived Usefulness [Day 1 (60 minutes)]
  • Percentage of Patients who Complete Qualitative Measure - Perceived Usability [Day 1 (60 minutes)]
  • Percentage of Patients who Complete Qualitative Measure - Perceived Use Challenges [Day 1 (60 minutes)]
  • Percentage of Patients who Complete Qualitative Measure - Perceived Value [Day 1 (60 minutes)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.